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Background: Metastatic dissemination can exist before a pathologically and clinically detectable manifestation. The
structural heterogeneity of colon cancer (CC) in histological sections with respect to the morphology of tumor
aggressiveness and composition of the tumor microenvironment raises the question of whether the microscopical
tumor architecture enables a discrimination of groups with different metastatic potential. This would result in an
assessment of the prognosis and provision of an ancillary tool for the therapeutic management after surgery,
beside the estimation of the local tumor extent.
Methods: In order to identify predictive biomarkers for metastasis of locally advanced CC, which can easily be
integrated into the pathologist’s daily routine diagnostic activity, we determined tumor budding, peritumoral
inflammation, extent of desmoplasia and necrosis, density of macro- and microvascular blood vessels and functional
state of lymphatics in the tumor center, invasive margin and tumor-free surrounding tissue in 86 non-metastatic,
lymphogenous-metastatic and haematogenous-metastatic, subserosa-invasive CC.
Results: Features influencing nodal metastasis in the univariate analysis included high tumor budding (p = 0.004),
high large vessel density in the subserosa (p = 0.043), abundant desmoplasia (p = 0.049), non-finger-like desmoplastic
pattern (p = 0.051) and absent lymphocellular intratumoral inflammation (p = 0.084). In the multivariate analysis,
with the exception of large vessel density, these pathomorphological features were independent risk factors for
lymphogenous metastasis (p = 0.023, p = 0.017, p = 0.037, p = 0.012, respectively) with a good discrimination ability
(AUC of 0.853). Features associated with distant metastasis in the univariate analysis included high tumor budding
(p = 0.002), low intratumoral small vessel density (p = 0.013), absent lymphocellular intratumoral inflammation
(p = 0.048) and abundant necrosis (p = 0.073). In the multivariate analysis only tumor budding was an independent
predictor for haematogenous metastasis (p = 0.007) with a good discrimination ability (AUC of 0.829).
Conclusions: Thus, mainly tumor budding but also the described structural characteristics of the peritumoral
tissue appears to reflect the metastatic potential of locally advanced CC and therefore should be stated in
pathological reports.
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The metastatic state of colon carcinoma (CC) deter-
mines its prognosis. The 5-year survival rate of patients
with distant metastasis is only about 10% compared to
approximately 60% with lymphogenous metastasis and
over 80% without metastasis [1]. Notably, metastatic dis-
semination could exist before a pathologically and clinic-
ally detectable manifestation. Hence the question arises,
whether a detailed analysis of the microscopical tumor
architecture on conventional histological sections and
the recognition of potential structural differences between
non-metastatic and metastatic cases could contribute to
determine the metastatic potential of CC, beside the local
tumor extent. Indeed, in histological sections a structural
heterogeneity of CC can be seen within the different zones
of the same tumor and between tumors of the same infil-
trating depth and grading.
The main histopathological characteristics of carcinoma
include the invasive growth pattern and the associated
changes in the surrounding stroma such as stromal des-
moplasia, peritumoral inflammatory reaction and necrosis.
These structural features reflect the interaction between
tumor cells and the “tumor microenvironment”, which
may promote tumor growth and progression [2,3].
CC show different growth patterns at the invasive front.
This so-called tumor budding is predictive of metastasis,
local recurrence and survival in CC [4]. As an adverse
prognostic factor tumor budding can help to stratify pa-
tients into more meaningful risk groups than TNM staging
alone, as well as for adjuvant chemotherapy in low tumor
stages [5]. Despite these data, a statement in the histo-
pathological report concerning the degree of tumor bud-
ding has not yet been widely applied.
During cancer growth, tumors not only destroy the
pre-existing extracellular matrix, but usually actively cre-
ate their own stroma, the so-called desmoplastic stroma
[6]. Desmoplasia may represent a barrier against cancer
diffusion or a stroma to build up and support the tumor.
Its role is controversially discussed regarding a tumor-
protecting versus host-protecting impact.
The presence of immuno-inflammatory cells in CC is
a common phenomenon [7]. The inflammatory response
can have dual effects in the progression of cancer. On one
side inflammation can promote tumor progression by
various pro-inflammatory cytokines that activate tumori-
genic pathways leading to increased growth and survival
of tumor cells [8]. On the other hand, inflammatory cells
have a host-protecting function in the sense of anti-tumor
immunity. In CC lymphocytic reactions are independent
prognostic factors for a better survival [9,10]. However,
whether and which immune infiltrates have an effect on
the metastatic potential of CC is not clear.
CC frequently shows characteristic necrotic debris in
glandular lumina, so-called “dirty necrosis”. Tumor necrosisis seen in rapidly proliferating tumors outgrowing their
blood supply, becoming hypoxic and finally necrotic. In
turn, release of growth-, survival- and angiogenic factors
support tumor progression and metastasis [11]. Tumor
necrosis has been proposed as a marker of poor prognosis
in carcinomas of various histogenetical origins [12]. In
CC, first histological studies provided evidence of tumor
necrosis as a parameter associated with progressive tumor
behavior [13,14].
Tumor vasculature, the network of blood and lymph-
atic vessels in and around a growing neoplasm is a basic
component of solid tumors is the tumor vasculature.
The vessel system is essential for adequate tumor tissue
oxygenation and nutritional supply but also for meta-
static spread [15,16]. Despite the fact that vascular anat-
omy in tumor tissue represents an important subject for
tumor growth and metastasis, reports with a detailed
histoarchitectural analysis in human tissue are rare.
In order to determine characteristic structural features
that could be associated with the process of metastasis
we investigated the histomorphology of the tumor and its
microenvironment in 86 non-metastatic, lymphogenous
and haematogenous metastatic, moderately differentiated,
subserosa-invasive CC. We characterized the grade of
tumor budding, the cell types of the intra- and peritumoral
inflammation as well as the extent and pattern of desmo-
plasia and necrosis. An essential part of our work was the
analysis of the density of intra- and peritumoral as well as
surrounding macro- and microvascular blood vessels. Add-
itionally, we determined the functional state of the tumor-
associated lymphatic vessels. The major aim of our study
was to identify relevant predictive biomarkers for the meta-
static potential of CC on the basis of conventional hist-
ology and routinely applicable immunohistochemistry,
which can easily be integrated into the pathologist’s report
in addition to the TNM-classification. We show that con-
ventionally treated primary tumor slides contain valuable
ancillary information on tumor behavior apart from fea-
tures such as tumor infiltration depth.
Methods
Ethics statement
For the investigation of CC tissues ethical approval was
granted by the Clinical Research Ethics Committee of the
federal state of Rhineland-Palatinate (Mainz, Germany).
Written informed consent of all patients was obtained.
Tissue samples
The colon tissue samples used in this study came from 86
patients with an average age of 65.2 (range 52–83) under-
going elective surgery for sporadic CC at the University of
Mainz during the years 1998–2003. None of the patients
received chemotherapy or radiation therapy before sur-
gery. The morphological classification of the carcinomas
Jayasinghe et al. BMC Cancer  (2015) 15:14 Page 3 of 14was conducted according to WHO specifications. All tu-
mors were staged following the guidelines of the TNM
Classification of Malignant Tumors [17]. With respect to
the T status all tumors investigated were T3 (infiltration of
subserosa) and moderately differentiated (G2). They were
separated into three groups according to metastatic status.
The first group comprised 37 cases without tumor metas-
tasis to regional lymph nodes or distant organs (N0/M0).
Among the remaining metastasizing cases, 24 were char-
acterized by lymphogenous (N+) and 25 by lymphogenous
and haematogenous metastases (M+). TNM-status con-
firms the tumor state at the time of pathological diagnosis.
Thus, the metastatic cases had already metastasized. The
metastasizing organ was in all M+ cases the liver.
Immunohistochemistry
All immunohistochemical reactions were conducted with
formalin-fixed and paraffin-embedded samples.
CD31, D2-40: After deparaffination heat-induced epi-
tope retrieval was performed in Tris-EDTA buffer pH 9,0
for 20 min. using a vegetable steamer. Non-specific bind-
ing was blocked by Dako REAL™ Peroxidase-Blocking
Solution (Dako, Hamburg, Germany) prior to incubation
with the primary antibody. For the immunohistochemical
staining procedure DAKO REAL™EnVision™Detection
System, Peroxidase/DAB+, Rabbit/Mouse was utilized fol-
lowing the provider’s instructions. The primary antibodies
mouse monoclonal CD31 (Dako, Hamburg, Germany)
and mouse monoclonal D2-40 (Signet, Dedham, MA,
USA) were applied at a dilution of 1:50 for 1 h at room
temperature. Sections were counterstained with Mayer’s
haematoxylin.
sm-actin: After deparaffination the primary antibody
mouse monoclonal sm-actin (Zytomed Systems, Berlin,
Germany) was added at a dilution of 1:800 for 45 mi-
nutes at room temperature. UltraVision Quanto Detec-
tion System HRP DAB (Thermo Scientific, Fremont,
CA, USA) was used for the staining procedure following
the provider’s instructions. Sections were counterstained
with Mayer’s haematoxylin.
Histopathological analysis
Haematoxylin and eosin (H.E.)-stained slides of the tumor
specimen were evaluated by two authors (CJ, NS) inde-
pendently without knowledge of the TNM-status.
Tumor budding was defined as single tumor cells and
oligocellular tumor cell clusters (≤5 cells) along the tumor
invasion front. It was graduated according to the scoring
system proposed by Nakamura et al.,[18] as none – low
(< 1/3 of invasion front) – moderate (> 1/3 < 2/3 of inva-
sion front) or strong (> 2/3 of invasion front).
Inflammation was determined on the basis of the type
composition of the detected inflammatory cells in H.E.
stained tissue. Four types of inflammatory reactionswere distinguished: pure lymphocytic, mixed (lympho-
cytic/neutrophilic), pure neutrophilic and histiocyte-
rich inflammation.
For tumor-desmoplasia-necrosis tissue distribution vi-
able tumor, desmoplastic stroma and necrosis were esti-
mated as percentage of the entire tumor section. The
total of the three pathological features was 100%. Add-
itionally tumor/desmoplasia and tumor/necrosis ratios
were calculated.
The desmoplastic pattern along the invasive front and
surrounding subserosal adipose tissue was divided into a
pushing, finger-like or net-like pattern. Necrotic areas in-
cluded stromal necroses and intraluminal necrotic debris
of the neoplastic glands.
Large vessel density (LVD): Arteries with a thick muscle
wall were considered as large vessels. Two areas were
counted at a low optical power (x 4 objective, field area
23.75 mm2). The final LVD was the mean value.
Small vessel density (SVD): Vessels with narrow lumina
but well definable up to five smooth muscle layers were
considered as small vessels. Five areas were counted at
medium optical power (x 10 objective, field area 3.80 mm2).
The final SVD was the mean value.
Microvascular density (MVD): Vessels with clearly de-
fined lumina or linear vessel shape were regarded as
microvessels. After immunohistochemical CD31 staining
three highly vascularized areas (hot spots) were chosen at
low optical power. Microvessel counting was performed at
higher magnification within the hot spots (x 20 objective,
field area 0.95 mm2). The final MVD was the mean value
of three appraised high power fields.
LVD, SVD and MVD were determined intratumorally
and along the invasion front, LVD and SVD additionally
in tumor surrounding non-neoplastic subserosal adi-
pose tissue.
Lymphatics were defined as D2-40-positive muscle layer-
free vessels. Lymphatic vessels were evaluated according to
the morphology of their lumina in the investigated tumor
zone (compressed, mixed (compressed/open) and open).
Statistical analysis
Data analysis was performed using SAS statistical software.
Differences between groups with respect to categorical var-
iables were analyzed by the following methods: Chi2 test,
Fisher’s exact test and logistic regression. P-values, odds ra-
tios (OR) and their 95% confidence intervals (CI) were
used in the interpretation. Differences between groups with
respect to continuous non-normal distributed variables
were analyzed by the Wilcoxon rank-sum test. All relevant
variables being significant (p < 0.05) or showing a strong
tendency towards significance (p < 0.1) in the univariate
analysis were included in a multivariate logistic model
and plotted as receiver operating characteristic (ROC)
curves to illustrate the predicted relevance. Additionally,
Table 1 Percentage distribution of histopathological
features in non-metastatic (N0/M0), lymphogenous-




none 24 4 0
weak 64 50 52
moderate 6 17 28
strong 6 29 20
Inflammation zone 1
none 3 21 16
granulocytic 3 0 8
mixed 46 33 28
lymphocytic 48 46 48
Inflammation zone 2
none 0 8 0
granulocytic 3 0 0
mixed 35 13 20
lymphocytic 59 79 68
xanthogranulomatous 3 0 12
Distribution (total 100%)
Tumor 52 50 48
Desmoplasia 34 38 35
Necrosis 14 12 17
Tumor/desmoplasia ratio
> median 59 33 48
≤ median 41 67 52
Tumor/necrosis ratio
> median 59 50 32
≤ median 41 50 68
Desmoplasia pattern
finger-like 46 21 36
pushing 27 46 20
net-like 27 33 44
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the estimation of the tumor-desmoplasia-necrosis distri-
bution with a test of reproducibility by calculating the
Spearman’s rank correlation coefficient (r) and with a test
of reliability by evaluating the weighted kappa coefficient
(κ) in 22 cases.
Results
To elucidate the relevance of the histomorphological fea-
tures, tumor budding, peritumoral inflammation, desmo-
plasia, tumor-associated necrosis as well as morphology
and density of tumor-associated blood and lymphatic ves-
sels for CC metastasis, we investigated non-metastatic (N0/
M0), lymphogenous-metastatic (N+), and haematogenous-
metastatic (M+) CC. In order to document the structural
and functional heterogeneity of tumor compartments we
subdivided the tumor tissue into three zones, tumor center
(zone 1), invasive margin (zone 2) and tumor-free sur-
rounding tissue (zone 3). The tumor center represents the
tumor compartment with the main mass of tumor with the
most nutritional and oxygen requirements. The tumor mar-
gin represents the invasive front site and is a dynamic
tumor-host interface. The surrounding tumor-free vessel-
bearing subserosal adipose tissue ensures an adequate nu-
tritional and oxygen supply.
Univariate analysis
Tumor budding
The graduation of tumor budding along the invasive front
according to the scoring system proposed by Nakamura
et al. [18] is a simple, reproducible method with high in-
terobserver accordance. With the conventional H.E.
staining disseminated single tumor cells and oligocel-
lular tumor clusters (≤5 tumor cells) at the invasive
margin were clearly identifiable. As shown in Table 1
the degree of this histopathological factor varied de-
pending on metastatic status. The dichotomization be-
tween low (0 to 1/3 of the invasion front) versus high
(>1/3 of the invasion front) tumor budding revealed
that high tumor budding correlates with increased
metastatic status. Whereas in only 10% of the non-
metastazing cases high budding was observed, the meta-
static carcinomas revealed high budding in about 50%
of the cases. The results were highly significant between
N0/M0 versus N+ (p = 0.0037) as well as N0/M0 versus
M+ (p = 0.0022) (Table 2).
Inflammation
Using the conventional H.E. staining four types of
inflammatory reaction in CC were identified: (1) pure
lymphocytic, (2) pure granulocytic, (3) mixed granulo-
cytic/lymphocytic and (4) histiocyte-rich. Inflammation
were seen intratumorally (zone 1) and along the invasive
front (zone 2). Lack of intratumoral inflammationeffectively did not exist in non-metastatic cases (Table 1).
In contrast, approximately 20% of the metastatic cases
showed no intratumoral inflammation. Neutrophil granu-
locytes as exclusive inflammatory cells were seen only in
three cases. A histiocyte-rich pattern was found in four
cases, but only at the invasion front. In barely 50% of the
cases, a lymphocellular infiltration was found in the tumor
center, independent of the metastatic status. In a markedly
higher percentage, a dominant, lymphocytic infiltration
along the invasive margin in all comparative groups was
demonstrated, especially in nodal positive carcinomas
(79% of the cases). In about 50% of the non-metastatic
and in approximately 30% of the metastatic cases a mixed
Table 2 Univariate logistic regression analysis showing associations of histopathological features in non-metastatic
(N0/M0) versus lymphogenous-metastatic (N+) and haematogenous-metastatic (M+) CC
N0/M0 vs. N+ N0/M0 vs. M+
OR (95% C.I.) p-value OR (95% C.I.) p-value
Tumor budding low vs. high 6.98 (1.88-25.92) 0.004 7.61 (2.07-27.97) 0.002
Inflammation zone 1 lymphocytic vs. non-lymphocytic 0.22 (0.04-1.23) 0.084 0.18 (0.03-0.99) 0.048
Inflammation zone 2 lymphocytic vs. non-lymphocytic 0.63 (0.08-4.83) NS 0.42 (0.06-2.71) NS
Tumor percentage distribution 0.99 (0.96-1.03) NS 0.98 (0.94-1.02) NS
Desmoplasia percentage distribution 1.02 (0.98-1.06) NS 1.01 (0.97-1.04) NS
Necrosis percentage distribution 0.98 (0.93-1.02) NS 1.01 (0.97-1.05) NS
Tumor/desmoplasia ratio (> median, ≤median) 0.34 (0.12-0.99) 0.049 0.63 (0.23-1.75) NS
Tumor/necrosis ratio (> median, ≤median) 0.68 (0.24-1.92) NS 0.38 (0.13-1.09) 0.073
Desmoplasia pattern finger-like vs. non-finger-like 0.31 (0.09-1.01) 0.051 0.66 (0.23-1.87) NS
Large vessel density zone 1 (> median, ≤median) 1.89 (0.63-5.62) NS 2.07 (0.71-6.06) NS
Large vessel density zone 2 (> median, ≤median) 2.61 (0.89-7.69) NS 0,92 (0.33-2.57) NS
Large vessel density zone 3 (> median, ≤median) 3.11 (1.03-9.32) 0.043 1.47 (0.53-4.09) NS
Small vessel density zone 1 (> median, ≤median) 0.79 (0.28-2.28) NS 0.24 (0.07-0.74) 0.013
Small vessel density zone 2 (> median, ≤median) 0.58 (0.20-1.65) NS 0.87 (0.31-2.42) NS
Small vessel density zone 3 (> median, ≤median) 1.30 (0.46-3.64) NS 1.20 (0.43-3.33) NS
Microvascular vessel density zone 1 (> median, ≤median) 0.89 (0.32-2.51) NS 0.87 (0.31-2.42) NS
Microvascular vessel density zone 2 (> median, ≤median) 1.37 (0.49-3.84) NS 0.52 (0.81-1.45) NS
Altered vessels zone 1 present vs. absent 0.83 (0.28-2.45) NS 0.93 (0.33-2.67) NS
Altered vessels zone 2 present vs. absent 1.41 (0.48-4.18) NS 1.12 (0.37-3.35) NS
Altered vessels zone 3 present vs. absent 0.93 (0.32-2.76) NS 0.74 (0.24-2.21) NS
Lymphatic vessels zone 1 open vs. compressed 0.29 (0.03-3.32) NS 0.59 (0.03-10.11) NS
Lymphatic vessels zone 2 open vs. compressed 1.59 (0.26-9.56) NS 1.22 (0.27-5.52) NS
Lymphatic vessels zone 3 open vs. compressed 1.62 (0.26-10.08) NS 1.77 (0.32-9.71) NS
Relevant variables being significant (p < 0.05) or showing a strong tendency towards significance (p < 0.1).
OR: odds ratio, C.I.: confidence interval, NS: no significant.
Jayasinghe et al. BMC Cancer  (2015) 15:14 Page 5 of 14type inflammation was seen in the intratumoral region.
This inflammation pattern was observed less commonly at
the tumor margin.
Comparing lymphocyte-associated (lymphocytic/mixed
type) inflammation versus none/pure granulocytic reac-
tion in zone 1, the results were just below statistical
significance in the nodal positive status (p = 0.084) but
significant in the cases of distant metastasis (p = 0.048)
(Table 2). The inflammation type in zone 2 showed no
significant differences between non-metastasized and
metastasized cases (Tables 1 and 2).
Necrosis and Desmoplasia
For each tumor specimen the percentage of viable tumor,
desmoplastic stromal reaction and necrosis was estimated.
The estimation of the percentage distribution tumor-
desmoplasia-necrosis was performed with a semiquantita-
tive scoring system. The reproducibility of the intra- and
interobserver variation was excellent and good, respect-
ively (r = 0.817 for intraobserver variation and r = 0.771for interobserver variation; p < 0.001). Both, the reliabil-
ities for the intraobserver variation [κ = 0.799 (95% C.
I.:0.577-1)] and for interobserver variation [κ = 0.753 (95%
C.I.:0.520-0.987)] were good. The distribution of these
three histopathological features did not reveal significant
differences between the three groups (Table 1). The vital
tumor mass was the largest component, accounting for
about 50% of the tumor volume in both non-metastatic
and lymphogenous-metastatic tumors.
As a next step we ascertained the tumor/necrosis ratio
and the tumor/desmoplasia ratio. The tumor/necrosis
ratio ranged from 0.5–70 for N0/M0, 0.75–40 for N+ and
0.5–12 for M+ with the median at 5.5 (Table 1). Abundant
necrosis was found in 68% of cases with distant metastasis
and only in 41% of metastatic-free cases. This difference
was just below the statistical significance level (p = 0.073)
(Table 2).
The tumor/desmoplasia ratio ranged from 0.43–5.33
in N0/M0, 0.5–5.33 in N+ and 0.5–6 in M+ with the me-
dian at 1.5 (Table 1). A prominent desmoplastic stromal
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tastasis and only in 41% in metastases-free cases. In the
binary logistic regression model the nodal positive cases
were strongly associated with a low tumor/desmoplasia
ratio (p = 0.049) (Table 2).
Desmoplasia showed three different patterns, pushing,
finger-like and net-like (Figure 1). The pushing pattern
dominated in lymphogenous-metastatic patients whereas
the finger-like pattern was commonest in non-metastatic
cases (Table 1). In both groups 46% of the cases expressed
the respective phenotype of peritumoral stromal reaction,
so that a strong tendency just below statistical significance
was observed (p = 0.051) (Table 2). The net-like pattern was
seen most frequently in haematogenous-metastatic cases.
Blood vessels
To evaluate the histological vascularization pattern of CC
we performed immunostaining for the pan-endothelial
marker CD31 and smooth muscle marker sm-actin which
produced very strong signals in blood vessels of various
sizes, that is, large and small vessels as well as microvascu-
lature (Figure 2A-C). The distribution and density of these
different sized vessels were analyzed in the tumor center,
tumor margin and tumor-free surrounding tissue.
Large vessels, essential for sufficient blood flow, were
seen not only in zone 3 but also intratumorally and along
the tumor front (Figures 3 and 4). It should be emphasized
that these arteries showed arteriosclerotic changes, char-
acterizing preexistent vessels. In zone 1 and 2 no signifi-
cant correlations were found between LVD and metastatic
status. In zone 3 nodal positive cases were associated
with a significantly higher LVD compared to cases with-
out metastasis (p = 0.043) (Table 2). LVD in N0/M0Figure 1 Desmoplastic pattern in CC. Pushing (A), finger-like (B) and neranged from 0 – 5.0/25 mm2 with the median at 0.5/
25 mm2 and in N+ from 0 – 5.5/25 mm2 with the me-
dian at 1,3/25 mm2 (Figure 3).
Small vessels, responsible for the maintenance of a
densely branched vascular network, were seen at different
intensity levels in all three zones (Figures 3 and 4). In zone
1 cases with distant metastasis were associated with a
lower SVD compared to N0/M0 (p = 0.013) (Table 2).
SVD in N0/M0 ranged from 0 – 6.8/4 mm2 with a median
value of 2,0/4 mm2 and in M+ from 0 – 3.2/4 mm2 with a
median of 1.2/4 mm2 (Figure 4). SVD in zone 2 and 3 re-
vealed no significant correlation with metastatic status.
MVD is known as a histological biomarker reflecting
the angiogenetic phenotype of the tumor. In the binary
logistic regression model with cut-off at the median no
significant correlation regarding metastatic status was
verifiable. The distribution of MVD between the three
investigated groups was similar in zone 1 as well as in
zone 2 (Figures 3 and 4). In zone 1 MVD in N0/M0
ranged from 14.7 – 49.7/mm2 (mean 25.8/mm2), in N+
from 15.7-52.3 (mean 26.9/mm2) and in M+ from 14.0 –
39.3/mm2 (mean 23.5/mm2). In zone 2 MVD in N0/M0
ranged from 13.3 – 57.7/mm2 (mean 24.8/mm2), in N+
from 10.7-74.7(mean 26.6 /mm2) and in M+ from 10.0 –
52.0/mm2 (mean 22.4 /mm2).
After closer examination of the blood vessel morphology
using sm-actin for detailed visualization of the vascular
muscle layer a mural alteration was noticed in some of the
vessels (Figure 2D). Typically, the tunica media is a layer of
continuously concentrically-arranged smooth muscle and
elastic fibers. Some blood vessels showed smooth muscle
cell hypoplasia with disorganized myogenic fragments and
replacement by connective tissue. The distribution of theset-like (C) pattern of desmoplasia in CC (H.E., x12,5).
Figure 2 Morphology of blood and lymphatic vessels in CC. (A) Large vessels (sm-actin (SMA), x100), (B) small vessels (SMA, x200) and
(C) microvascular vessels (CD31, x40) in CC. (D) Altered blood vessels with discontinuously hypoplastic smooth muscle cell layer (SMA, x200).
(E) Intratumoral compressed lymphatic vessels (D2-40, x200). (F) Lymphatic vessels at the tumor periphery with open lumina (D2-40, x100).
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zones and among the three groups was strikingly similar
(Table 3). In all three tumor compartments in about 33%
of the cases this interesting histopathological feature could
be demonstrated and was independent of metastatic status.
Lymphatic vessels
To detect lymphatic vessels sections were stained with
the specific lymphatic endothelial marker D2-40. In al-
most all investigated cases intratumoral lymphatics were
seen (Table 3). Only in 16% and 17% respectively of
non-metastatic and lymphogenous metastatic and in
20% of the haematogenous metastatic cases lymphatics
were not detectable in tumor-associated regions. Under
normal circumstances lymphatic vessels are partially orfully collapsed due to the lack of smooth muscle cover-
age and low pressure within the lymphatic system. How-
ever, for lymphatic vessel invasion open lumina are an
important condition. For that reason we focused our at-
tention on the functional state of lymphatic vessels in
the three tumor zones. In this context, we recognized
three functional lumen patterns, predominantly only com-
pressed, predominantly only open and partly compressed/
partly open lumina. Interestingly, whereas most of the
intratumoral lymphatics were compressed, an increasing
number of open lymphatics along the invasive tumor mar-
gin was observed and a clear dominance of lymph vessels
with open lumina could be seen in zone 3 (Figure 2E and
F). No significant differences could be established among
the three metastatic groups (Table 2).
Figure 3 Vascular densitiy in three different zones in non-metastatic (N0/M0) and lymphogenous metastatic (N+) CC. Box plot of large
vessel density (LVD), small vessel density (SVD) and microvascular vessel density (MVD) in zone 1, zone 2 and zone 3 between non-metastatic
(N0/M0) and lymphogenous metastatic (N+) CC. The dark lines denote the median and the open diamond the mean value of each group.
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statement concerning the relevance for lymphangiosis
and haemangiosis carcinomatosa cannot be made.
Multivariate analysis
Factors influencing nodal metastasis in the univariate
analysis included high tumor budding, high large vessel
density in the surrounding tumor-free tissue abundant
desmoplasia, non-finger-like desmoplastic pattern and ab-
sent lymphocyte-containing intratumoral inflammation.
In the multivariate analysis, except LVD, these patho-
morphological features were independent risk factors for
lymphogenous metastasis (p = 0.023, p = 0.017, p = 0.037,
p = 0.012, respectively) (Table 4).
Taking into account these identified independent fac-
tors, their ability to discriminate between non-metastatic
and lymphogenous metastatic group was assessed by a
ROC curve. The vertical axis represents sensitivity, which
is the proportion of predicted metastatic cases among pa-
tients with lymph node metastasis, and the horizontal axis
represents specifity, which is the proportion of predicted
non-metastastic cases among patients who were de facto
without metastasis. The more concave the curve, the bet-
ter the prediction ability. The area under the curve (AUC)
is a numerical assessment of concavity. An AUC of 0.5 in-
dicates that prediction is based purely on random chance,and an AUC of 1 indicates that the outcome can be per-
fectly predicted. In our study the AUC for nodal metasta-
sis was 0.853 suggesting good discrimination (Figure 5).
Factors associated with distant metastasis in the univari-
ate analysis included high tumor budding, low intratu-
moral small vessel density, absent lymphocyte-containing
intratumoral inflammation and abundant necrosis. In the
multivariate analysis only tumor budding was proven to
be an independent predictor for haematogenous metasta-
sis (p = 0.007) (Table 4). Figure 6 illustrates good discrim-
ination ability (AUC of 0.829).
Notably, in none of the investigated factors could signifi-
cant differences between lymphogenously and haemato-
genously metastatic cases be assessed.
Discussion
This study is one of the first attempts to identify rele-
vant biomarkers in predicting metastasis in CC by de-
tection of structural differences between non-metastatic,
lymphogenous-metastatic and haematogenous-metastastic
cases in conventional histological sections. From all inves-
tigated histological features in tumor tissue of CC high
tumor budding, defined as single tumor cells or small
tumor cell clusters (≤5 cells) sprouting in more than a
third of the total invasion front, emerged as the most con-
vincing predictive factor for both lymph node and distant
Figure 4 Vascular densitiy in three different zones in non-metastatic (N0/M0) and haematogenous metastatic (M+) CC. Box plots of large
vessel density (LVD), small vessel density (SVD) and microvascular vessel density (MVD) in zone 1, zone 2 and zone 3 between non-metastatic (N0/M0)
and haematogenous metastatic (M+) CC. The dark lines denote the median and the open diamond the mean value of each group.
Jayasinghe et al. BMC Cancer  (2015) 15:14 Page 9 of 14metastasis. In the literature a strong association between
tumor budding and the presence of lymph node metastases
is well documented, especially in early submucosa-invasive
tumors [19-23]. The significance of tumor budding for
distant CC metastasis has received little attention as yet.
However, two studies showed that the presence of tumor
budding correlates with liver and peritoneal metastases
[24,18]. In the present study high tumor budding was the
only independent factor in multivariate analysis associated
with distant metastasis. The prevailing hypothesis con-
cerning the biological importance of tumor budding is
that it represents an epithelial-mesenchymal transition,
a biological process characterized by increased migra-
tory capacity and invasiveness [25]. Additionally, it has
been hypothesized that budding cells have cancer stem
cell character, resulting in enhanced invasive and meta-
static properties [26,27]. Despite different scoring sys-
tems lacking standardized graduation, tumor budding
has proved to be a reliable prognostic marker for CC
[28]. In this context, our results underline the fact that
this histomorphological feature is an independent pre-
dictive factor not only for lymph node but also for dis-
tant metastasis of locally advanced CC with good
discrimination ability. Tumor budding could be used as a
target to discriminate between different aggressive behavior
patterns in subserosa-invasive, moderately differentiated
CC. In view of these data, a histopathological reportshould include information on tumor budding, beyond
the obligatory TNM-status and grading. The establish-
ment of a consistent, generally accepted, simple applic-
able scoring system is necessary.
In our study absence of intratumoral lymphocytic in-
flammation was another histological characteristic associ-
ated with nodal and distant metastases. In the multivariate
analysis this observation was an independent predictor for
lymph node metastasis, but not for distant metastasis. In
nearly all non-metastasizing cases lymphocyte infiltration,
whether pure or combined with neutrophils, was found
within the tumor. These results indicate a predominant
role for a tumor-associated adaptive immunity within the
tumor itself in the prevention of tumor progression in CC.
The protective role of lymphocytes in CC was discussed
by a number of study groups. In an overview article
Roxburgh and McMillan [29] presented the published
data on the relationship between tumor inflammatory
cell infiltration and patient survival over a 40 year period.
Collectively, the presence of tumor-infiltrating lympho-
cytes indicates a favorable prognosis. In this context, the
comparison between tumors of the same local anatomical
extent in the present study suggests a tumor-infiltrating
lymphocyte-dependent decreased metastatic potential. In
accordance with our results another study demonstrated,
that CC metastases in lymph nodes and in the liver are de-
tected when the immune infiltrate in the primary tumor
Table 3 Percentage distribution of altered blood vessels
and lymphatic vessels according to their functional status
intratumorally (zone 1), along the invasive front (zone 2)
and extratumorally (zone 3) in non-metastatic (N0/M0),
lymphogenous-metastatic (N+) and haematogenous-
metastatic (M+) colon carcinomas
N0/M0 N+ M+
Altered vessels zone 1
present 38 33 36
absent 62 67 64
Altered vessels zone 2
present 30 38 32
absent 70 62 68
Altered vessels zone 3
present 35 33 28
absent 65 67 72
Lymphatic vessels zone 1
absent 3 9 4
compressed 78 58 68
mixed 19 33 24
open 0 0 4
Lymphatic vessels zone 2
absent 13 8 16
compressed 38 42 56
mixed 46 42 24
open 3 8 4
Lymphatic vessels zone 3
absent 30 21 24
compressed 11 12 16
mixed 16 17 24
open 43 50 36
Altered vessels were defined as blood vessels showing a discontinuous,
hypoplastic smooth muscle cell layer (see Figure 2D).
Table 4 Multivariate logistic regression analysis showing asso
non-metastatic (N0/M0) versus lymphogenous-metastatic (N+
N0/M0 vs
OR (95%
Tumor budding low vs. high 5.99 (1.28-
Inflammation zone 1 lymphocytic vs.non-lymphocytic 0.06 (0.01-
Tumor/Necrosis ratio (> median, ≤median)
Tumor/Desmoplasia ratio (> median, ≤median) 0.17 (0.04-
Desmoplastic pattern finger-like vs. non-finger-like 0.18 (0.03-
Large vessel density zone 3 (> median, ≤median) 2.437 (0.61
Small vessel density zone 1 (> median, ≤median)
OR: odds ratio, CI: confidence interval, NS: no significant.
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Dukes stage was associated with less peritumoral
lymphocyte infiltrate [31]. Interestingly, in virtually all
investigated cases independent of the metastatic status a
lymphocyte-containing inflammatory response was found
in the tumor margin. In this context, Zlobec et al. [32] re-
ported that lymphocytic inflammation at the invasion
front does not appear to be an independent prognostic
factor in CC. However, gene expression profiling and im-
munohistochemistry with evaluation of immune cell sub-
types demonstrated that type, density and location of
immune cells within the tumor samples seem to be a bet-
ter predictor of patient survival than the histopathological
methods currently used to stage CC [33]. The present
study has focused only on the inflammatory cell types de-
tected by conventional H.E. staining and their distribution
intratumorally and at the invasive front. Furthermore, it
assessed neither their density nor the immunhistochemi-
cally determined detailed composition and functional state
of immune cell subsets. Nonetheless, our preliminary find-
ings indicate that the daily routine H.E. stained tissue
sections are a convenient and inexpensive way to study
intratumoral inflammation and to gain valuable informa-
tion on probable tumor metastatic behavior.
In CC, studies of desmoplasia give conflicting results.
Several studies suggest that a peritumoral stromal re-
sponse is an adverse prognostic factor [34-36]. By
contrast, Coporale et al. [37] favor the view that desmo-
plasia is a protective factor for patient survival. In 2D
and 3D co-culture systems the cell-cell contact between
fibroblast and CC cells evoked an increase of extracellu-
lar matrix density and led to inhibited tumor migration
and invasion [38]. In our study, abundant desmoplasia
(tumor/desmoplasia ratio ≤ 1.5) was an independent
predicting factor for lymph node metastasis. Besides dif-
ferences in the quantity of desmoplasia, we also ob-
served distinct expansion patterns without knowledge
of their biological significance. While positive nodal cases
showed mostly a pushing desmoplastic stroma pattern,
non-metastatic cases exhibited a finger-like pattern. Thisciations of relevant histopathological features in
) and haematogenous-metastatic (M+) CC
. N+ N0/M0 vs. M+
CI) p-value OR (95% CI) p-value
27.90) 0.023 8.70 (1.83-41.42) 0.007






Figure 5 Receiver-operator characteristic (ROC) curve for predicting nodal metastasis in CC. ROC curve indicating the sensitivity and
specificity of the relevant histopathological features (tumor budding, lymphocellular intratumoral inflammation and abundant desmoplasia with
non-finger-like pattern) for predicting nodal metastasis in CC.
Jayasinghe et al. BMC Cancer  (2015) 15:14 Page 11 of 14characteristic spatial extent of desmoplasia was also an
independent predictor for nodal status in the multivari-
ate analysis.
Tumor necrosis is a common histological feature in
colon cancer, but its biological significance is unclear. So
far, only two studies describe the correlation between
the extent of histologic tumor necrosis and the TNM-
stage. Both research groups reported that extent of necro-
sis was associated significantly with lymph node metastasis
[13,14]. In our study abundant necrosis (tumor/necrosis
ratio ≤ 5.5) was seen tendentially more often in cases with
distant metastasis. The amount of necrosis in metastatic-
free and nodally positive cases was approximately equal.
Further investigations are required to determine the role
of tumor necrosis in CC metastasis.
The tumor tissue of CC was composed of three basic
histological components, namely the cancer cells them-
selves, the (desmoplastic) interstitium and the necrotic
areas. The viable carcinomatous glands were the largest
component accounting about 50% of the tumor volume
in both non-metastatic and lymphogenous-metastatic tu-
mors. It is clear that the establishment of a functionally in-
tegrated vascular system is essential for tumor growth andmetastasis. In the present study the density of large and
small blood vessels as well as the microvasculature in
three strategically significant regions, namely intratumoral,
invasive margin and adjacent host tissue, were chosen as a
quantitative parameter to describe the vascular network.
The large vessels were not only seen in the surrounding
subserosal adipose tissue but also within the tumor and
along the invasion front. The detection of arteriosclerotic
change gave evidence of preexisting vessels. This observa-
tion is remarkable, for large vessels are usually not found
within the muscle wall and the parts closer to the intes-
tinal lumen. We suggest that the traction effect of the des-
moplasia could play an important role by adducting these
vessels into the tumor center and front.
Since macrovasculature is responsible for abundant
blood transport, this vascular concentration is essential for
adjacent nutrition supply. In our study lymphogenous-
metastatic CC showed significantly more often a relatively
high density of large vessels in the tumor-free peritumoral
region. Haematogenous-metastatic CC presented signifi-
cantly more often a relatively low density of small vessels
in the intratumoral region. Since these vessels form a net-
work that regulates local blood perfusion, this fact could
Figure 6 Receiver-operator characteristic (ROC) curve for predicting distant metastasis in CC. ROC curve indicating the sensitivity and
specificity of tumor budding as solely relevant histopathological feature for predicting distant metastasis in CC.
Jayasinghe et al. BMC Cancer  (2015) 15:14 Page 12 of 14explain the abundant necrotic areas in these cases. To our
knowledge these observations have not been described in
conventional histological sections in detail before. Add-
itionally, in about one third of the CC and independent of
the metastatic status we found altered blood vessels with
discontinuously hypoplastic muscle wall layers, intra- as
well as extratumorally. We hypothesize that these vessels
could reflect immature tumor vascular entities, which en-
able tumors to adapt more easily to extremely harsh con-
ditions because of their leaky architecture with higher
fluid and solute exchange ability. In addition, these imma-
ture vessels could enhance tumor cell entry into the
circulation and hence distant metastasis. In another study
immature microvessels without pericyte coverage were de-
scribed in correlation with haematogenous metastasis of
CC [39]. Microvascular density (MVD) is considered to be
the morphological gold standard to assess the neovascula-
ture in human tumors [40]. A meta-analysis found a sta-
tistically significant inverse relationship between MVD
and survival in CC [41]. In our study MVD measurement
in central tumor portions and at the surrounding part of
the tumor was without significant differences between
non-metastatic and metastatic CC. Our results indicate
that MVD is not sufficient to predict metastasis in locally
advanced CC. In this tumor status, the evaluation ofexpression of angiogenic factors in tumor specimens
might provide an alternative to MVD in assessing tumor
angiogenic activity with more functional information.
In almost all CC intratumoral lymphatics were detect-
able but were mostly collapsed and showed compressed
lumina. In contrast to this, directly beneath the deep in-
filtration front in the peritumoral region and mainly in
the tumor-free surrounding tissue lymphatic vessels with
open lumina predominated. This morphological distribu-
tion suggests a prevalent role of peritumoral lymphatics in
lymphogenous metastasis, because collapsed intratumoral
lymphatics are not suitable for tumor cell dissemination.
Collapsed intratumoral lymphatics could reflect a mech-
anical stress situation induced by the vessel pressure in
the desmoplastic tumor tissue. By a compensatory mech-
anism the resulting elevated lymph pressure could lead to
a dilatation of the lymphatics in the tumor periphery.
Another research group has made the same observations
in CC using color stereoscopic lymphography [42]. We
conclude that the tumor margin and the surrounding
tissue with open lymphatics are the most favorable site
of entry of tumor cells into lymphatics. Notably, no
significant differences between non-metastatic and meta-
static cases were found concerning this specific lympho-
vascular histoarchitecture.
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Taken the results together, tumor budding represents an
independent predictive biomarker with a good discrimin-
ation ability for both lymphogenous and haematogenous
metastasis in moderately differentiated, subserosa-invasive
CC. Absence of intratumoral lymphocytic inflammation
and abundant desmoplasia with non-finger-like pattern
could provide additional independent predictive factors
for lymph node metastasis. Abundant tumor necrosis with
low intratumoral small vessel density is a common feature
of distant metastasis. Thus, tumor budding and the local
peritumoral situation seem to be able to reflect the
metastatic potential. A statement of these histological
features in the histopathological report could provide an
ancillary tool for the further imaging and therapeutic
management after surgery. Since metastatic dissemin-
ation could exist before a pathologically and clinically
detectable manifestation, these features could also be con-
sidered in metastatic-free cases in locally advanced CC.
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